Related Experiment Video
Updated: Aug 13, 2026

Gas Chromatography-Mass Spectrometry Paired with Total Vaporization Solid-Phase Microextraction as a Forensic Tool
Published on: May 25, 2021
The Thrills and Spills of GHB: Patterns and Negative Events Connected with Use in a Large Community Sample
Twyla Michnevich1, Felix Betzler1, Lukas Roediger1
1Department of Psychiatry and Neurosciences, CCM, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
None:
Introduction: Gamma-hydroxybutyric acid (GHB) and its precursor gamma-butyrolactone (GBL) are psychoactive substances commonly associated with men who have sex with men (MSM) and sexualized substance use contexts. Large-scale studies exploring broader sociodemographic characteristics and substance use behaviors among GHB/GBL users remain scarce. Methods: A convenience sample was recruited online through nightlife contexts to complete an anonymous online-questionnaire with a one-year follow-up. The survey assessed sociodemographic data, use of GHB/GBL and other psychoactive substances, GHB/GBL-related adverse events, and lifetime psychiatric diagnosis. Participants were categorized as occasional or frequent users based on the past 12 months. Results: Among 2196 participants, 47.4% reported GHB/GBL use within the past year; among these, 72.9% were occasional users (< 1x/week), and 27.1% frequent users (≥ 1x/week). At one-year follow-up, 10.9% of the sample was retained. The majority of users were male, with 40% of frequent users and 42% of occasional users identifying as homosexual. Frequent users reported more negative events associated with use (e.g., unconsciousness and overdose) and screened more often for problematic use (CAGE-AID). GHB/GBL use frequency was positively associated with methamphetamine, research chemical, and benzodiazepine use, and negatively associated with alcohol use. Conclusions: This study provides insight into GHB use in a diverse sample and confirms higher levels of adverse effects and problematic use patterns among frequent users. Findings highlight the need for prevention and harm reduction strategies that go beyond MSM/chemsex contexts. Broader, inclusive public health approaches are essential to reduce risks and address the evolving landscape of GHB use.
Related Concept Videos
Generalized Anxiety Disorder
Deindividuation
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

